share_log

天坛生物(600161.SH):所属上海血制拟出资2500万元增加宜良浆站注册资本

Tiantan Biology (600161.SH): Affiliated Shanghai Blood Systems plans to invest 25 million yuan to increase the registered capital of Yiliang Pulp Station

Gelonghui Finance ·  Dec 25, 2023 04:25

On December 25, Gelonghui Biotech (600161.SH) announced that the company's Shanghai Blood System fully invested 25 million yuan to increase the registered capital of Yiliang Pulp Station. After the capital increase was completed, the registered capital of Yiliang Pulp Station increased from 15 million yuan to 40 million yuan, and Shanghai Blood Systems holds 100% of the shares. The capital increase was funded by Shanghai Blood Products itself.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment